FDA grants fast Track status to Enterome’s EO2463 for follicular lymphoma
16th October 2025 Uncategorised 0
Designation supports phase 3 launch in watch-and-wait patients in 2026

More: FDA grants fast Track status to Enterome’s EO2463 for follicular lymphoma
Source: News
